Last year, Biomerica Inc generated 3.18M USD for its biggest-performing segment, Clinical Lab. The Asia made the largest contribution, accounting for 1.72M USD last year. For the latest quarter, Biomerica Inc reported the revenue of 621.00K USD for the period ending 2026-02-28, which came from the top-performing segment, Clinical Lab. Europe contributed the highest revenue, at 287.00K USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Clinical Lab

Contract Manufacturing

OTC

Physicians’ Office

Lab Supplies

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Clinical Lab

3.18M(59.89%)

3.24M(59.76%)

3.31M(62.00%)

3.06M(16.24%)

3.08M(42.74%)

2.92M(43.67%)

Contract Manufacturing

1.07M(20.15%)

741.00K(13.68%)

610.00K(11.43%)

459.00K(2.43%)

552.00K(7.67%)

305.76K(4.57%)

OTC

1.05M(19.75%)

1.43M(26.33%)

1.17M(21.90%)

1.09M(5.77%)

766.00K(10.64%)

1.27M(18.97%)

Physicians’ Office

11.00K(0.21%)

12.00K(0.22%)

250.00K(4.68%)

14.26M(75.56%)

2.80M(38.91%)

2.19M(32.80%)

Lab Supplies

--(--)

3.00K(0.04%)

--(--)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

Asia

United States

Europe

Middle East

South America

Othe Foreign

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Asia

1.72M(32.35%)

1.88M(34.74%)

2.02M(37.85%)

13.38M(70.88%)

1.91M(26.50%)

1.87M(27.89%)

United States

1.66M(31.22%)

1.28M(23.73%)

1.47M(27.53%)

997.00K(5.28%)

548.00K(7.61%)

445.00K(6.65%)

Europe

1.30M(24.42%)

1.44M(26.56%)

1.80M(33.68%)

4.34M(22.99%)

4.30M(59.74%)

2.43M(36.37%)

Middle East

630.00K(11.86%)

800.00K(14.77%)

39.00K(0.73%)

70.00K(0.37%)

192.00K(2.67%)

314.00K(4.69%)

South America

8.00K(0.15%)

11.00K(0.20%)

11.00K(0.21%)

90.00K(0.48%)

250.00K(3.47%)

1.61M(24.13%)

Othe Foreign

--(--)

18.00K(0.27%)